arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 2310.01426q-bio.QMcs.LG
收藏

REMEDI:原发性硬化性胆管炎疾病进展的强化学习驱动适应性代谢建模

REMEDI: REinforcement learning-driven adaptive MEtabolism modeling of primary sclerosing cholangitis DIsease progression

University of Illinois at Urbana-Champaign(伊利诺伊大学厄巴纳-香槟分校);University of Missouri School of Medicine(密苏里大学医学院);Mayo Clinic(梅奥诊所)

Chang Hu, Krishnakant V. Saboo, Ahmad H. Ali, Brian D. Juran, Konstantinos N. Lazaridis, Ravishankar K. Iyer

AI总结:

针对原发性硬化性胆管炎中胆汁酸代谢改变致肝损伤的问题,提出融合微分方程机理模型与强化学习的REMEDI框架,模拟机体适应过程,结果与已有发现一致且支持早期抑酸药的治疗潜力。

摘要:

原发性硬化性胆管炎(PSC)是一种罕见疾病,其胆汁酸代谢改变会导致持续性肝损伤。本文提出REMEDI框架,该框架可捕捉PSC进展过程中的胆汁酸动态变化及机体的适应性反应,可助力探索治疗方案。REMEDI将描述胆汁酸代谢的基于微分方程(DE)的机理模型与强化学习(RL)相结合,以持续模拟机体对PSC的适应过程。适应的一个目标是通过调节参与胆汁酸代谢的酶来维持稳态,这些酶对应微分方程的参数。REMEDI利用RL来近似PSC中的适应过程,将稳态视为奖励信号,将微分方程参数的调整视为相应动作。在真实世界数据上,REMEDI生成的胆汁酸动态变化和参数调整与已发表的研究结果一致。此外,我们的结果支持文献中的相关讨论,即早期给予抑制胆汁酸合成的药物可能对PSC治疗有效。

英文摘要:

Primary sclerosing cholangitis (PSC) is a rare disease wherein altered bile acid metabolism contributes to sustained liver injury. This paper introduces REMEDI, a framework that captures bile acid dynamics and the body's adaptive response during PSC progression that can assist in exploring treatments. REMEDI merges a differential equation (DE)-based mechanistic model that describes bile acid metabolism with reinforcement learning (RL) to emulate the body's adaptations to PSC continuously. An objective of adaptation is to maintain homeostasis by regulating enzymes involved in bile acid metabolism. These enzymes correspond to the parameters of the DEs. REMEDI leverages RL to approximate adaptations in PSC, treating homeostasis as a reward signal and the adjustment of the DE parameters as the corresponding actions. On real-world data, REMEDI generated bile acid dynamics and parameter adjustments consistent with published findings. Also, our results support discussions in the literature that early administration of drugs that suppress bile acid synthesis may be effective in PSC treatment.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑